We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide to Tabrecta (capmatinib) dosage and usage for treating specific types of non-small cell lung cancer (NSCLC) in adults. Learn about strengths, how to take it, missed doses, overdose, and senior considerations.
Facing a diagnosis of non-small cell lung cancer (NSCLC) can bring a wave of questions and concerns. Understanding your treatment options is a vital step in navigating this journey. Tabrecta, with its active ingredient capmatinib, represents a significant advancement in targeted cancer therapy. Unlike traditional chemotherapy, Tabrecta is a kinase inhibitor, designed to specifically target certain types of lung cancer. This means it works by interfering with the signals that cancer cells need to grow and multiply. This article aims to demystify the dosage and usage of Tabrecta, providing clear, practical information for patients in India and their families. We'll cover how it's taken, what strengths are available, what to do if you miss a dose or take too much, and special considerations for older adults. Remember, this information is a guide; your doctor's prescription is always the final word on your treatment plan.
Tabrecta is a prescription medication approved for adults with a specific type of non-small cell lung cancer (NSCLC). This isn't just any lung cancer; it's for cases where the cancer has spread beyond the lungs or has particular genetic mutations. Specifically, it targets NSCLC that has mutations in the MET gene, particularly METex14 skipping. This targeted approach is a cornerstone of modern cancer treatment, offering a more precise way to combat the disease.
It's important to understand that Tabrecta is a targeted therapy, not chemotherapy. This distinction is significant. Chemotherapy often affects rapidly dividing cells throughout the body, leading to a range of side effects. Targeted therapies like Tabrecta are designed to zero in on the specific abnormalities within cancer cells, potentially leading to a different side effect profile and a more focused treatment strategy.
Tabrecta belongs to a class of drugs known as kinase inhibitors. Kinases are proteins that play a role in cell signaling – essentially, they act like messengers, telling cells what to do. In certain types of NSCLC, specific kinases, like the MET receptor tyrosine kinase, are overactive or mutated. This overactivity can drive cancer cell growth and survival.
Tabrecta works by inhibiting these specific kinases. By blocking the signals that tell cancer cells to grow and divide uncontroll12 hours apart. This consistent level in your body helps maintain its therapeutic effect. You can take Tabrecta with or without food, which offers flexibility in your daily routine. However, always follow your doctor's specific advice regarding meals and medication timing.
Taking more Tabrecta than prescribed can lead to serious health consequences. It's essential to adhere strictly to your doctor's dosage instructions. If you suspect you've taken too much Tabrecta, do not wait. Call your doctor immediately. You can also reach out to the National Poisons Information Centre at 1800-11-7777 or their online resources for guidance. In cases of severe symptoms, such as difficulty breathing, extreme dizziness, or loss of consciousness, call emergency services like 108 or your local emergency number right away, or go to the nearest hospital emergency room.
Are there different dosage requirements for adults aged 65 years and older? Generally, Tabrecta's recommended dosage doesn't change based solely on age. However, doctors always consider a patient's overall health, kidney and liver function, and other medical conditions when determining the most appropriate dose. If you are 65 or older, or have any pre-existing health conditions, discuss this with your doctor. They will monitor you closely throughout your treatment.
Similarly, if you have kidney or liver issues, your doctor will assess your condition and may adjust your dosage or monitor you more frequently. Tabrecta is processed by the body, and impaired kidney or liver function can affect how the medication works and how it's cleared from your system.
Taking medication consistently is key to successful treatment. Here are some practical tips to help you manage your Tabrecta dosage:
Proper storage and disposal of medications are important for safety and environmental reasons. Always store Tabrecta at room temperature, away from light and moisture. Keep it out of reach of children and pets. If you have leftover medication or expired Tabrecta, ask your doctor or pharmacist about the best way to dispose of it. Many pharmacies have take-back programs for unused medications.
It's essential to maintain open communication with your healthcare team. You should contact your doctor immediately if:
Your doctor is your primary resource for managing your Tabrecta treatment effectively and safely.
It's crucial to discuss all medications, including over-the-counter drugs and supplements, with your doctor before starting Tabrecta. Some medications can interact with Tabrecta, affecting its efficacy or increasing the risk of side effects. Your doctor will review your complete medication list to ensure safety.
Tabrecta is typically prescribed as a long-term treatment. If you and your doctor find that it is working well for you and is well-tolerated, you will likely continue taking it for an extended period. The duration of treatment is highly individualized.
Common side effects can include nausea, vomiting, diarrhea, fatigue, shortness of breath, swelling, and increased liver enzymes. It's important to report any side effects to your doctor, as they can often be managed. Your doctor will monitor you for side effects throughout your treatment.
Tabrecta is designed to control the growth of certain types of lung cancer and help manage symptoms. While it can be highly effective, it is generally considered a treatment to manage the disease rather than a cure. The goal is to extend survival and improve quality of life.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026